It activates both receptor pathways simultaneously
One example is Orforglipron, an oral GLP-1 candidate from Lilly that recently completed Phase 3 clinical trials for weight management
Parasitology 145 (8), 10591064
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Finally, by adding the innovative GBB, Carnitine concentrations are increased in the body
Ding T, Yan W, Zhou T, Shen W, Wang T, Li M, et al